Albert Mitrani Organicell Regenerative Medicine, Inc. (OCEL) insider trading activity

Albert Mitrani is Chief Executive Officer of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 152 Million shares of OCEL, which is worth approximately $175 Million. The most recent transaction as insider was on May 13, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.27 per share, resulting in proceeds of $13,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152M

0% 3M change

0% 12M change

Total Value Held $175 Million

Albert Mitrani Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2021	SELL Open market or private sale	$13,500 $0.27 p/Share	50,000 Reduced 0.03%	168,525,190 Common Stock
May 12 2021	SELL Open market or private sale	$13,000 $0.26 p/Share	50,000 Reduced 0.03%	168,575,190 Common Stock
May 11 2021	SELL Open market or private sale	$24,000 $0.32 p/Share	75,000 Reduced 0.04%	168,625,190 Common Stock
May 10 2021	SELL Open market or private sale	$13,000 $0.26 p/Share	50,000 Reduced 0.03%	168,700,190 Common Stock
May 07 2021	SELL Open market or private sale	$23,400 $0.26 p/Share	90,000 Reduced 0.05%	168,750,190 Common Stock
May 06 2021	SELL Open market or private sale	$10,400 $0.26 p/Share	40,000 Reduced 0.02%	168,840,190 Common Stock
May 05 2021	SELL Open market or private sale	$21,750 $0.29 p/Share	75,000 Reduced 0.04%	168,880,190 Common Stock
May 04 2021	SELL Open market or private sale	$20,000 $0.4 p/Share	50,000 Reduced 0.03%	168,955,190 Common Stock
Apr 30 2021	SELL Open market or private sale	$25,000 $0.5 p/Share	50,000 Reduced 0.03%	169,005,190 Common Stock
Apr 29 2021	SELL Open market or private sale	$24,000 $0.48 p/Share	50,000 Reduced 0.03%	169,055,190 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 2.87%	169,105,190 Common Stock
Feb 10 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 2.96%	164,105,190 Common Stock
Jan 27 2021	BUY Grant, award, or other acquisition	-	5,000,000 Added 3.05%	159,105,190 Common Stock
Dec 21 2020	BUY Grant, award, or other acquisition	-	15,000,000 Added 8.87%	154,105,190 Common Stock
Sep 23 2020	BUY Grant, award, or other acquisition	$1,960,000 $0.28 p/Share	7,000,000 Added 5.34%	124,105,190 Common Stock
Sep 17 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 3.47%	139,105,190 Common Stock
Sep 03 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 3.59%	134,105,190 Common Stock
Aug 25 2020	BUY Grant, award, or other acquisition	$150,000 $0.03 p/Share	5,000,000 Added 3.73%	129,105,190 Common Stock

Albert Mitrani

Chief Executive Officer

Miami, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL

Account